| 前收市價 | 6.00 |
| 開市 | 6.19 |
| 買盤 | 7.55 |
| 賣出價 | 9.55 |
| 拍板 | 170.00 |
| 到期日 | 2025-03-21 |
| 今日波幅 | 6.00 - 6.19 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 161 |
ZacksGilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Gilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or metastatic urothelial cancer fails to achieve its primary endpoint.
Motley Fool3 Dividend Stocks to Double Up on Right Now
The stories for these great dividend stocks are better than many might think.
ZacksAre Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?
Investors need to pay close attention to AbbVie (ABBV) stock based on the movements in the options market lately.
